slides · global inventory
27 Cost Of Inaction
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 31,900
Current window 21,721-21,750
Pages 1,064
Rows per page 30
Loop
21,721-21,750 of 31,900
37
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
38
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
39
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
40
The fourth agenda item is highlighted with a blue circle, indicating the current or primary focus of the presentation.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
05
The slide uses a Gantt-style layout to represent drug development stages.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
The slide uses a chromosome icon for the lead asset and a fast-forward icon for the pipeline strategy.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
35
The chart uses a combination of bar and line graphs to demonstrate long-term financial performance.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
11
Uses a visual timeline/process flow to explain the disease progression.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
12
Uses data from Ladabaum U, et al. (JNCI, 2022) to justify the importance of AA detection thresholds.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
09
Uses authority-citation to establish urgency and market relevance.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
Uses a 'Before-After-Bridge' style logic (Characteristics - Limitations = Unlocked Potential).Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
The slide uses a process flow diagram to map clinical outcomes to specific data points.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
12
This is a credibility-building slide showcasing academic validation of the company's technology.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
13
The slide uses a human silhouette as a central anchor to map specific clinical indications to anatomical locations.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
14
Focuses on patients who failed or could not tolerate standard azole or IV Amphotericin B therapies.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
15
The slide uses a timeline diagram combined with two line charts to demonstrate clinical efficacy and safety.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
16
The slide highlights both the clinical urgency and the commercial orphan disease opportunity.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
05
Uses a before-after framing to position the platform as a solution to industry-wide pain points.MaxCyte | Results Presentation Deck | 25 slides · MaxCyte
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
MaxCyte | Results Presentation Deck | 25 slidesMaxCyte | Results Presentation Deck | 25 slides · MaxCyte
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
The central hub is 'Accelerate Product Development', surrounded by four key pillars: Shared Momentum, Clinically-Validated Platform, Unparalleled Support, and Streamlined Regulatory Process.MaxCyte | Results Presentation Deck | 25 slides · MaxCyte
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide uses a process flow diagram to show the funnel of partnerships and clinical programs.MaxCyte | Results Presentation Deck | 25 slides · MaxCyte
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
04
Includes a footer with brand logos and a disclaimer about non-GAAP measures.Membership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
Membership Collective Group | Investor Presentation Deck | 31 slidesMembership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
06
The slide uses a split-screen layout to contrast growth and operational efficiency strategies.Membership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
Membership Collective Group | Investor Presentation Deck | 31 slidesMembership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
08
Includes a leadership announcement at the bottom right.Membership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
09
Membership Collective Group | Investor Presentation Deck | 31 slidesMembership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
10
Includes margin percentages for contribution metrics.Membership Collective Group | Investor Presentation Deck | 31 slides · Soho House & Co Inc.
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
05
MindMed | Results Presentation Deck | 20 slidesMindMed | Results Presentation Deck | 20 slides · MindMed
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
06
The chart uses a horizontal bar format to represent progress through clinical phases (Pre-clinical to Phase 3).MindMed | Results Presentation Deck | 20 slides · MindMed
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit